Skip to main content

Want a detailed portfolio tracker?

Apollomics (APLM) P/E (2021 - 2026)

Apollomics (APLM) P/E from Nov 26, 2021 to Jul 21, 2026. The TTM Apollomics (APLM) P/E is -1.66. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Apollomics (APLM)

YearP/EChange
2026-1.66+0.88%
2025-1.64+185.27%
2024-0.58-89.50%
2023-5.49-90.69%
2022-58.94+4.33%
2021-56.49N/A

Comparison Apollomics (APLM) P/E with competitors

Apollomics (APLM) P/E is -1.66.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.10%
NBYStablecoin Development Corp0.00-100.26%
ENLVEnlivex Ltd0.07-104.51%
FGENFibroGen Inc0.24-114.47%
CHRSCoherus Biosciences Inc0.85-151.15%
FBIOFortress Biotech Inc0.95-157.21%
ORMPOramed Pharmaceuticals Inc1.50-190.60%
AGENAgenus Inc3.01-281.42%
INVAInnoviva Inc3.15-290.12%
VXRTVaxart Inc3.55-313.97%
CRMDCorMedix Inc3.63-318.72%
CVACCureVac N.V.4.45-367.98%
GLPGGalapagos NV4.86-392.89%
SRPTSarepta Therapeutics Inc4.88-394.29%
ABEOAbeona Therapeutics Inc5.39-424.75%
ABUSArbutus Biopharma Corp5.60-437.30%
ZVRAZevra Therapeutics Inc5.89-454.87%
SPROSpero Therapeutics Inc6.23-475.44%
CGENCompugen Ltd6.31-480.60%
RIGLRigel Pharmaceuticals6.87-514.24%
SLXNSilexion Therapeutics Corp7.30-539.80%
OMEROmeros Corporation9.26-658.11%
AUPHAurinia Pharmaceuticals Inc9.58-677.77%
PLXProtalix BioTherapeutics Inc10.89-756.50%
ACADAcadia Pharmaceuticals Inc11.73-806.98%
TBPHTheravance Biopharma Inc12.26-839.15%
ADMAAdma Biologics Inc12.42-848.55%
HRMYHarmony Biosciences Holdings Inc13.82-933.07%
SABSSAB Biotherapeutics Inc14.14-952.11%
NAGENiagen Bioscience Inc14.82-993.22%
INCYIncyte Corp15.82-1053.77%
REGNRegeneron Pharmaceuticals Inc15.86-1055.82%
PBYIPuma Biotechnology Inc17.32-1143.77%
CPRXCatalyst Pharmaceuticals Inc17.44-1151.22%
EXELExelixis Inc17.54-1157.17%
TGTXTG Therapeutics Inc18.97-1243.25%
MDXGMimedx Group Inc20.55-1338.88%
XOMAXOMA Royalty Corp22.87-1478.90%
ARGXArgen X SE24.30-1564.70%
CTMXCytomX Therapeutics Inc24.82-1596.23%
XOMAOXOMA Royalty Corp25.34-1627.80%
HALOHalozyme Therapeutics Inc25.62-1644.61%
XOMAPXOMA Royalty Corp25.67-1647.41%
VRTXVertex Pharmaceuticals Inc27.99-1787.54%
RPRXRoyalty Pharma plc - Class A28.69-1829.30%
SLNOSoleno Therapeutics Inc29.02-1849.06%
ASNDAscendis Pharma A/S30.09-1913.57%
LGNDLigand Pharmaceuticals Inc - Class B37.91-2385.35%
BMRNBiomarin Pharmaceutical Inc42.21-2644.55%
KRYSKrystal Biotech Inc45.34-2833.33%
ONCBeiGene Ltd69.54-4291.93%
PHARPharming Group N.V.75.03-4622.58%
TECHBio-Techne Corp101.96-6246.10%
VCELVericel Corp109.92-6726.12%
ALNYAlnylam Pharmaceuticals Inc117.96-7211.00%
GMABGenmab140.29-8556.80%
TLXTelix Pharmaceuticals Ltd162.15-9874.66%
CORTCorcept Therapeutics Inc212.86-12931.16%